These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26498163)

  • 1. Impact of remote monitoring on reducing the burden of inappropriate shocks related to implantable cardioverter-defibrillator lead fractures: insights from a French single-centre registry.
    Souissi Z; Guédon-Moreau L; Boulé S; Kouakam C; Finat L; Marquié C; Brigadeau F; Wissocque L; Mouton S; Montaigne D; Klug D; Kacet S; Lacroix D
    Europace; 2016 Jun; 18(6):820-7. PubMed ID: 26498163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial.
    Guédon-Moreau L; Kouakam C; Klug D; Marquié C; Brigadeau F; Boulé S; Blangy H; Lacroix D; Clémenty J; Sadoul N; Kacet S
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):763-70. PubMed ID: 24602062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring.
    Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L
    Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards eradication of inappropriate therapies for ICD lead failure by combining comprehensive remote monitoring and lead noise alerts.
    Ploux S; Swerdlow CD; Strik M; Welte N; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1125-1134. PubMed ID: 29858871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks.
    Turakhia MP; Zweibel S; Swain AL; Mollenkopf SA; Reynolds MR
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):. PubMed ID: 28196927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life.
    Merchant FM; Jones P; Wehrenberg S; Lloyd MS; Saxon LA
    J Am Heart Assoc; 2014 Nov; 3(6):e001289. PubMed ID: 25385346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A report on the impact of remote monitoring in patients with S-ICD: Insights from a prospective registry.
    Ninni S; Delahaye C; Klein C; Marquie C; Klug D; Lacroix D; Brigadeau F; Potelle C; Kouakam C; Finat L; Guedon-Moreau L
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):349-355. PubMed ID: 30609077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE
    Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.
    Nishii N; Miyoshi A; Kubo M; Miyamoto M; Morimoto Y; Kawada S; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):463-470. PubMed ID: 29194831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial injury secondary to ICD shocks: insights from patients with lead fracture.
    Sham'a RA; Nery P; Sadek M; Yung D; Redpath C; Perrin M; Sarak B; Birnie D
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):237-41. PubMed ID: 23998856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes.
    Parthiban N; Esterman A; Mahajan R; Twomey DJ; Pathak RK; Lau DH; Roberts-Thomson KC; Young GD; Sanders P; Ganesan AN
    J Am Coll Cardiol; 2015 Jun; 65(24):2591-2600. PubMed ID: 25983009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.